FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893902671> ?p ?o ?g. }

• W2893902671 endingPage "1648" @default.
• W2893902671 startingPage "1641" @default.
• W2893902671 abstract "We investigated the incidence of ESKD after surgical management of kidney cancer in the Australian state of Queensland, and described patterns in the initiation of kidney replacement therapy resulting from kidney cancer across Australia.All newly diagnosed cases of kidney cancer in the Australian state of Queensland between January of 2009 and December of 2014 were ascertained through the Queensland Cancer Registry. There were 2739 patients included in our analysis. Patients who developed ESKD were identified using international classification of disease-10-coded hospital administrative data. Incidence rate and 3-year cumulative incidence were calculated, and multivariable Cox proportional hazards models were used to identify factors associated with ESKD. Additional descriptive analysis was undertaken of Australian population data.The incidence rate of ESKD in all patients was 4.9 (95% confidence interval [95% CI], 3.9 to 6.2) per 1000 patient-years. The 3-year cumulative incidence was 1.7%, 1.9%, and 1.0% for all patients, and patients managed with radical or partial nephrectomy, respectively. Apart from preoperative kidney disease, exposures associated with increased ESKD risk were age≥65 years (adjusted hazard ratio [aHR], 2.0; 95% CI, 1.2 to 3.2), male sex (aHR, 2.3; 95% CI, 1.3 to 4.3), preoperative diabetes (aHR, 1.8; 95% CI, 1.0 to 3.3), American Society of Anesthesiologists classification ≥3 (aHR, 4.0; 95% CI, 2.2 to 7.4), socioeconomic disadvantage (aHR, 1.6; 95% CI, 0.9 to 2.7), and postoperative length of hospitalization ≥6 days (aHR, 2.1; 95% CI, 1.4 to 3.0). Australia-wide trends indicate that the rate of kidney replacement therapy after oncologic nephrectomy doubled between 1995 and 2015, from 0.3 to 0.6 per 100,000 per year.In Queensland between 2009 and 2014, one in 53 patients managed with radical nephrectomy and one in 100 patients managed with partial nephrectomy developed ESKD within 3 years of surgery.This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2018_09_28_CJASNPodcast_18_1_.mp3." @default.
• W2893902671 created "2018-10-05" @default.
• W2893902671 creator A5001910883 @default.
• W2893902671 creator A5004382366 @default.
• W2893902671 creator A5014925967 @default.
• W2893902671 creator A5017481619 @default.
• W2893902671 creator A5021763640 @default.
• W2893902671 creator A5043394711 @default.
• W2893902671 creator A5046989492 @default.
• W2893902671 creator A5051879362 @default.
• W2893902671 creator A5060639317 @default.
• W2893902671 creator A5076314741 @default.
• W2893902671 creator A5079200192 @default.
• W2893902671 creator A5082309685 @default.
• W2893902671 creator A5090803103 @default.
• W2893902671 date "2018-09-28" @default.
• W2893902671 modified "2023-09-26" @default.
• W2893902671 title "End-Stage Kidney Disease following Surgical Management of Kidney Cancer" @default.
• W2893902671 cites W1484956255 @default.
• W2893902671 cites W1843076471 @default.
• W2893902671 cites W1903302369 @default.
• W2893902671 cites W1904470192 @default.
• W2893902671 cites W1922859388 @default.
• W2893902671 cites W1966604070 @default.
• W2893902671 cites W1983959921 @default.
• W2893902671 cites W1990257742 @default.
• W2893902671 cites W1996270118 @default.
• W2893902671 cites W2000445173 @default.
• W2893902671 cites W2007495351 @default.
• W2893902671 cites W2016224996 @default.
• W2893902671 cites W2017988961 @default.
• W2893902671 cites W2027026910 @default.
• W2893902671 cites W2038981426 @default.
• W2893902671 cites W2044349739 @default.
• W2893902671 cites W2061326496 @default.
• W2893902671 cites W2080457366 @default.
• W2893902671 cites W2090381471 @default.
• W2893902671 cites W2119144996 @default.
• W2893902671 cites W2149432171 @default.
• W2893902671 cites W2151654671 @default.
• W2893902671 cites W2164317031 @default.
• W2893902671 cites W2515362935 @default.
• W2893902671 cites W2599961018 @default.
• W2893902671 cites W2609016393 @default.
• W2893902671 cites W2610758168 @default.
• W2893902671 cites W2740705396 @default.
• W2893902671 cites W2779866318 @default.
• W2893902671 cites W2787148801 @default.
• W2893902671 cites W2804020118 @default.
• W2893902671 doi "https://doi.org/10.2215/cjn.06560518" @default.
• W2893902671 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6237064" @default.
• W2893902671 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30266837" @default.
• W2893902671 hasPublicationYear "2018" @default.
• W2893902671 type Work @default.
• W2893902671 sameAs 2893902671 @default.
• W2893902671 citedByCount "11" @default.
• W2893902671 countsByYear W28939026712018 @default.
• W2893902671 countsByYear W28939026712019 @default.
• W2893902671 countsByYear W28939026712020 @default.
• W2893902671 countsByYear W28939026712021 @default.
• W2893902671 countsByYear W28939026712022 @default.
• W2893902671 countsByYear W28939026712023 @default.
• W2893902671 crossrefType "journal-article" @default.
• W2893902671 hasAuthorship W2893902671A5001910883 @default.
• W2893902671 hasAuthorship W2893902671A5004382366 @default.
• W2893902671 hasAuthorship W2893902671A5014925967 @default.
• W2893902671 hasAuthorship W2893902671A5017481619 @default.
• W2893902671 hasAuthorship W2893902671A5021763640 @default.
• W2893902671 hasAuthorship W2893902671A5043394711 @default.
• W2893902671 hasAuthorship W2893902671A5046989492 @default.
• W2893902671 hasAuthorship W2893902671A5051879362 @default.
• W2893902671 hasAuthorship W2893902671A5060639317 @default.
• W2893902671 hasAuthorship W2893902671A5076314741 @default.
• W2893902671 hasAuthorship W2893902671A5079200192 @default.
• W2893902671 hasAuthorship W2893902671A5082309685 @default.
• W2893902671 hasAuthorship W2893902671A5090803103 @default.
• W2893902671 hasBestOaLocation W28939026711 @default.
• W2893902671 hasConcept C120665830 @default.
• W2893902671 hasConcept C121332964 @default.
• W2893902671 hasConcept C121608353 @default.
• W2893902671 hasConcept C126322002 @default.
• W2893902671 hasConcept C141071460 @default.
• W2893902671 hasConcept C207103383 @default.
• W2893902671 hasConcept C2778527826 @default.
• W2893902671 hasConcept C2778653478 @default.
• W2893902671 hasConcept C2780091579 @default.
• W2893902671 hasConcept C2780227381 @default.
• W2893902671 hasConcept C2781068499 @default.
• W2893902671 hasConcept C2908647359 @default.
• W2893902671 hasConcept C44249647 @default.
• W2893902671 hasConcept C50382708 @default.
• W2893902671 hasConcept C61511704 @default.
• W2893902671 hasConcept C71924100 @default.
• W2893902671 hasConcept C72563966 @default.
• W2893902671 hasConcept C88879693 @default.
• W2893902671 hasConcept C99454951 @default.
• W2893902671 hasConceptScore W2893902671C120665830 @default.
• W2893902671 hasConceptScore W2893902671C121332964 @default.

• next